RARγ overexpression within colorectal carcinoma, cholangiocarcinoma, and clear cell renal and hepatocellular carcinomas were measured for the cancer cell populations as a whole, rather than just for the CSC component. The gene discussed is RARG; the disease is cholangiocarcinoma.